A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this research Study is to assess how safe and well tolerated the Study Drug Itacitinib is in combination with corticosteroids compared to placebo in patients who have chronic graft versus host disease (cGVHD). This Study will also assess the ways in which these drugs are broken down in the body and eliminated, and the effects that the drugs may have on subjects' diseases.
Details
| Condition | oncology |
|---|---|
| Age | 18years - 99years |
| Clinical Study Identifier | 03584516 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.